OGI Key Statistics, Chart & Performance
The current stock price of OGI is 1.6 USD. In the past month the price decreased by -21.18%. In the past year, price increased by 1.27%.
OGI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to OGI. When comparing the yearly performance of all stocks, OGI is a bad performer in the overall market: 68.99% of all stocks are doing better.
OGI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to OGI. OGI has a bad profitability rating. Also its financial health evaluation is rather negative.
OGI Financial Highlights
Over the last trailing twelve months OGI reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS increased by 60.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.4% | ||
| ROE | -7.09% | ||
| Debt/Equity | 0.22 |
OGI Forecast & Estimates
8 analysts have analysed OGI and the average price target is 2.52 USD. This implies a price increase of 57.3% is expected in the next year compared to the current price of 1.6.
For the next year, analysts expect an EPS growth of 104.73% and a revenue growth 22.53% for OGI
OGI Ownership
OGI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 47.35 | 984.41B | ||
| JNJ | JOHNSON & JOHNSON | 21.02 | 525.73B | ||
| MRK | MERCK & CO. INC. | 12.42 | 271.66B | ||
| PFE | PFIZER INC | 7.98 | 145.10B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.27 | 110.38B | ||
| ZTS | ZOETIS INC | 19.44 | 54.31B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.51 | 22.56B | ||
| VTRS | VIATRIS INC | 5.43 | 14.58B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 25.17 | 12.00B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.30B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.58B | ||
| GPCR | STRUCTURE THERAPEUTICS INC | N/A | 5.52B |
Related stock screener links
About OGI
Company Profile
Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Company Info
ORGANIGRAM GLOBAL INC
35A English Dr
Moncton NEW BRUNSWICK E1E 3X3 CA
CEO: Greg Engel
Employees: 1178
Phone: 15063841571
ORGANIGRAM GLOBAL INC / OGI FAQ
Can you describe the business of ORGANIGRAM GLOBAL INC?
Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Can you provide the latest stock price for ORGANIGRAM GLOBAL INC?
The current stock price of OGI is 1.6 USD. The price decreased by -0.62% in the last trading session.
Does OGI stock pay dividends?
OGI does not pay a dividend.
What is the ChartMill rating of ORGANIGRAM GLOBAL INC stock?
OGI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is OGI stock listed?
OGI stock is listed on the Nasdaq exchange.
What is the market capitalization of OGI stock?
ORGANIGRAM GLOBAL INC (OGI) has a market capitalization of 214.93M USD. This makes OGI a Micro Cap stock.